So here is my one post for the day:
There are varying opinions on the possibility of stock value at the current structure. I prefer ole One-eye's breakdown of course as it looks so much pertier. Based on what I have found with other bio and pharma stocks, I can see those values and then some. Just by virtue of the fact that there are several different ways Regen can obtain revenues with their treatments and discoveries, some of which they can have at least 10 year exclusivity if they opt to take through trials, without selling outright to a BP, and having said treatment marketed through and for them. That means mega $$$ of course, depending on the treatment. That, although not part of the plan that Koos has spelled out (at least not that we are privy to), is very plausible once they have generated substantial revenue from selling patents and a couple of licensing's.
So, all that said, if Regen generates an income of let's say a 1/2 billion dollars in the next five years (it could happen!), what could the pps be? Or, let's say 200 million next year because a BP bought Hema 1 & 2 from them? What would the pps be? Or, 350 million resulting from deals for the siRNA use?
What is the potential of the pps with significant income and not as the income is today?
Thanks in advance.
Sometimes, you just have to walk away, let the dust settle and look at it all from a different perspective.
